ROTATE

Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE) (ROTATE)

Near Add Your Location

Sorting 2 by

University of Rochester Medical Center Wilmot Cancer Center
Strong Memorial Hospital
Rochester, NY
  • Not yet accepting
  • Show Principal Investigator
Smilow Cancer Hospital at Yale New Haven
New Haven, CT
  • Accepting patients
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.